Logo image
Discriminative Stimulus and Anxiolytic-Like Effects of the Novel Compound CL 273,547
Journal article   Peer reviewed

Discriminative Stimulus and Anxiolytic-Like Effects of the Novel Compound CL 273,547

Kimberly E. Vanover, Lei Zhang and James E. Barrett
Experimental and clinical psychopharmacology, v 2(3)
01 Aug 1994

Abstract

Life Sciences & Biomedicine Pharmacology & Pharmacy Psychiatry Psychology Psychology, Biological Psychology, Clinical Science & Technology Social Sciences
CL 273,547 is a novel nonbenzodiazepine with anxiolytic activity, but with a lesser tendency to produce sedative effects. CL 273,547 was established as a discriminative stimulus in rats (Rattus norvegicus). Triazolam and CL 284,846 substituted for CL 273,547 and decreased response rates. Buspirone did not substitute for CL 273,547, whereas pentobarbital substituted in the majority of the rats. Effects on punished responding of pigeons (Columba livia) also were examined as a preclinical evaluation of anxiolytic-like activity. CL 273,547 increased punished responding in pigeons at doses that had little effect on responding that was not punished. The benzodiazepine receptor antagonist flumazenil partially blocked the discriminative stimulus effects of CL 273,547 in rats and the effects of CL 273,547 on punished responding of pigeons. These results suggest that the nonbenzodiazepine CL 273,547 has benzodiazepine-like discriminative stimulus and anxiolytic effects.

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Pharmacology & Pharmacy
Psychiatry
Psychology, Biological
Psychology, Clinical
Logo image